Overcoming COVID-19 in West African countries: is herd immunity an option?

被引:0
|
作者
Ilesanmi, Olayinka Stephen [1 ,2 ]
Akande, Abayomi [2 ]
Afolabi, Aanuoluwapo Adeyimika [1 ]
机构
[1] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Oyo State, Nigeria
[2] Univ Coll Hosp, Dept Community Med, Ibadan, Oyo State, Nigeria
关键词
COVID-19; herd immunity; vaccine; case fatality rate; deaths;
D O I
10.11604/pamj.supp.2020.35.103.24217
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The coronavirus infection (COVID-19) to date has no vaccine or effective treatment. Herd immunity offers indirect protection to susceptible members of the population. If the acquired immunity of a community rises above 67%, then a gradual decline in the number of incident cases is recorded. How many deaths would have occurred in the West African countries by the time at least 67% of our people are infected with the present case fatality rate (CFR)? The objective of this study was to develop a forecast of the number of COVID-19 deaths that would be recorded to attain herd immunity for each country in West-Africa. We predicted the numbers of deaths using publicly available demographic and COVID-19 data. To attain herd immunity in West Africa 5.2 million COVID-19 deaths would have occurred assuming the CFR is maintained at the current rates in the region. Attention should be focused on strategies that would limit the spread of infection and protect the most vulnerable population groups while the race to develop an effective vaccine should be hastened.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [1] COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad, Mohammed
    Al-Saqqaf, Inas Shakeeb
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 106 : 79 - 82
  • [2] Herd immunity for COVID-19
    Burki, Talha Khan
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 135 - 136
  • [3] COVID-19 and Herd Immunity
    Alp, Sehnaz
    Altintas, Hakan
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (02): : 232 - 237
  • [4] Herd immunity and COVID-19
    Chen, J.
    Ye, L.
    Zhou, M. -Y.
    Cheng, Y. -R.
    Wang, M. -W.
    Feng, Z. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4064 - 4065
  • [5] COVID-19 and herd immunity
    Ashton, John
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2022, 115 (02) : 76 - 77
  • [6] Role of Herd Immunity in COVID-19
    Ruchi
    Chakole, Swarupa
    Reddy, Himabindu
    Mehendale, Ashok
    [J]. JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (08): : 258 - 262
  • [7] Digital herd immunity and COVID-19
    Bulchandani, Vir B.
    Shivam, Saumya
    Moudgalya, Sanjay
    Sondhi, S. L.
    [J]. PHYSICAL BIOLOGY, 2021, 18 (04)
  • [8] COVID-19, herd immunity and vaccine
    Tin, Sim Sai
    Wiwanitkit, Viroj
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01)
  • [9] COVID-19: individual and herd immunity
    Bach, Jean-Francois
    Berche, Patrick
    Chatenoud, Lucienne
    Costagliola, Dominique
    Valleron, Alain-Jacques
    [J]. COMPTES RENDUS BIOLOGIES, 2021, 344 (01) : 7 - 18
  • [10] The dilemma of herd immunity for COVID-19
    Nejadghaderi, Seyed Aria
    Safiri, Saeid
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2578 - 2579